Live Breaking News & Updates on Reata Pharmaceuticals Company Profile

Stay updated with breaking news from Reata pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reata Pharmaceuticals (NASDAQ:RETA) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. A number of other analysts have also recently weighed in on the stock. 888 restated a reiterates rating on shares of Reata Pharmaceuticals in a research note […] ....

Stifel Nicolaus , Manmeet Singh Soni , Carter Bir , Reata Pharmaceuticals Company Profile , Analyst Recommendations For Reata Pharmaceuticals , Reata Pharmaceuticals , Belpointe Asset Management , Institutional Investors Weigh In On Reata Pharmaceuticals , News Ratings For Reata Pharmaceuticals Daily , Securities Exchange Commission , Reata Pharmaceuticals Price Performance , China Universal Asset Management Co , International Assets Investment Management , Visionpoint Advisory Group , Reata Pharmaceuticals Inc , Free Report , Get Free Report , Singh Soni , Exchange Commission , Dawn Carter Bir , Asset Management , Assets Investment Management , Universal Asset Management , Point Advisory Group , Strs Ohio , Reata Pharmaceuticals Daily ,

StockNews.com Initiates Coverage on Reata Pharmaceuticals (NASDAQ:RETA)

StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock. Several other research analysts have also commented on RETA. LADENBURG THALM/SH SH lowered shares of Reata Pharmaceuticals from a buy rating to a neutral rating and […] ....

Robertw Baird , Andrea Loewen , Leerink Partnrs , China Universal Asset Management Co , Securities Exchange Commission , Reata Pharmaceuticals Company Profile , Institutional Investors Weigh In On Reata Pharmaceuticals , Visionpoint Advisory Group , Reata Pharmaceuticals Price Performance , Jefferies Financial Group , Belpointe Asset Management , Reata Pharmaceuticals Inc , Analyst Recommendations For Reata Pharmaceuticals , Reata Pharmaceuticals , News Ratings For Reata Pharmaceuticals Daily , International Assets Investment Management , Free Report , Financial Group , Get Free Report , Director Shamim Ruff , Exchange Commission , Asset Management , Assets Investment Management , Universal Asset Management , Point Advisory Group , Strs Ohio ,

Andrea Loewen Sells 3,175 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Stock

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) SVP Andrea Loewen sold 3,175 shares of Reata Pharmaceuticals stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $172.03, for a total value of $546,195.25. Following the sale, the senior vice president now directly owns 28,416 shares in the […] ....

Andrea Loewen , Leerink Partnrs , Robertw Baird , News Ratings For Reata Pharmaceuticals Daily , Quarter For Reata Pharmaceuticals , Securities Exchange Commission , International Assets Investment Management , Reata Pharmaceuticals , Reata Pharmaceuticals Stock , Reata Pharmaceuticals Company Profile , Belpointe Asset Management , Reata Pharmaceuticals Inc , Visionpoint Advisory Group , Institutional Investors Weigh In On Reata Pharmaceuticals , China Universal Asset Management Co , Get Free Report , Exchange Commission , Asset Management , Assets Investment Management , Universal Asset Management , Point Advisory Group , Strs Ohio , Reata Pharmaceuticals Daily , Nasdaq Reta , Insider Trading , Nsider Trades ,

Reata Pharmaceuticals (NASDAQ:RETA) Reaches New 12-Month High at $172.15

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $172.15 and last traded at $172.11, with a volume of 341874 shares traded. The stock had previously closed at $172.05. Wall Street Analysts Forecast Growth Several equities research analysts have recently […] ....

Stifel Nicolaus , Andrea Loewen , Manmeet Singh Soni , Suvretta Capital Management , Reata Pharmaceuticals Stock Performance , News Ratings For Reata Pharmaceuticals Daily , Nisa Investment Advisors , Reata Pharmaceuticals , Reata Pharmaceuticals Inc , Reata Pharmaceuticals Company Profile , First Light Asset Management , Get Free Report , Singh Soni , Investment Advisors , Capital Management , Light Asset Management , Reata Pharmaceuticals Daily , Nasdaq Reta ,

Short Interest in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Decreases By 38.1%

Short Interest in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Decreases By 38.1%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Stifel Nicolaus , Carter Bir , China Universal Asset Management Co , Belpointe Asset Management , Cantor Fitzgerald , Visionpoint Advisory Group , International Assets Investment Management , Reata Pharmaceuticals Stock Performance , News Ratings For Reata Pharmaceuticals Daily , Institutional Trading Of Reata Pharmaceuticals , Reata Pharmaceuticals Inc , Reata Pharmaceuticals , Reata Pharmaceuticals Company Profile , Get Free Report , Dawn Carter Bir , Director Shamim Ruff , Asset Management , Assets Investment Management , Universal Asset Management , Point Advisory Group , Strs Ohio , Reata Pharmaceuticals Daily ,